Android Apple

NUHS's CD7 CAR-T cell therapy shows promise for leukaemia

By Yahoo! Finance   |   2 months ago
NUHS's CD7 CAR-T cell therapy shows promise for leukaemia

A new CD7 chimeric antigen receptor (CAR)-T cell therapy developed by NUHS in Singapore shows promising results in treating relapsed or refractory T-cell acute lymphoblastic leukaemia (T-ALL).

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.